Patients may experience a variety of side effects such as rash, loss of appetite, cough, nausea, dry conjunctivitis, and other side effects during treatment with Erlotinib.
Erlotinib belongs to a kind of anti-tumor drug, which is used to treat patients with locally advanced or metastatic non-small cell lung cancer. The drug has certain side effects, which may cause patients to experience various side effects such as rash, decreased appetite, nausea, vomiting, conjunctivitis, stomatitis, etc. The degree of side effects is mostly 1 to 2 degrees, and most of the patients don’t need to interrupt the use of the drug.
Before using the drug, patients need to consult a doctor, for the existence of allergic reactions to the product, during pregnancy, children patients are prohibited from using this drug, for the existence of liver function impairment should be used with caution. Lung, liver and kidney functions should be monitored in time to avoid serious complications.
If patients experience other physical symptoms during the use of the drug, they should promptly inform the doctor, who will determine whether to stop the drug or take the necessary measures to alleviate the symptoms according to the patient’s physical condition.